Home

Piramal Pharma Ltd Quarterly Result

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Net Profit - Last Quarter

₹ 22.59 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Piramal Pharma Ltd for the Sep '24 is ₹ 2320 crore as compare to the Jun '24 revenue of ₹ 1993 crore. This represent the growth of 16.408783%.
  • The ebitda of Piramal Pharma Ltd for the Sep '24 is ₹ 419.98 crore as compare to the Jun '24 ebitda of ₹ 246.43 crore. This represent the growth of 70.42569%.
  • The net profit of Piramal Pharma Ltd for the Sep '24 is ₹ 22.59 crore as compare to the Jun '24 net profit of ₹ -88.64 crore. This represent the decline of -125%.

Results Analysis

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025230.65
14 Jan 2025234.85
13 Jan 2025232.45
10 Jan 2025221.65
09 Jan 2025237.25
08 Jan 2025245.3
07 Jan 2025250.35
06 Jan 2025247.55
03 Jan 2025254.85
02 Jan 2025257.35

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Piramal Pharma Ltd News Hub

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S

Read more

17 Sep 2024

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization

Read more

30 Sep 2024

Piramal Pharma to discuss results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

14 Jan 2025

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe

Read more

15 Oct 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

TranscriptPPT

Feb 2023

Transcript

Jan 2023

PPT

Nov 2022

Transcript

FAQs for Quarterly Results of Piramal Pharma Ltd

What key financial metrics are included in Piramal Pharma Ltd's quarterly results?

Key financial metrics in Piramal Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Piramal Pharma Ltd announce its quarterly results?

Piramal Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Piramal Pharma Ltd's quarterly performance impact its stock price?

Piramal Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Piramal Pharma Ltd's quarterly results on dividends?

The impact of Piramal Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Piramal Pharma Ltd's quarterly results?

Yes, Piramal Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions